Related Experiment Video
Updated: Jul 11, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.2K
The 2022 Banff Meeting Lung Report
Elizabeth N Pavlisko1, Benjamin A Adam2, Gerald J Berry3
1Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
Summary
Lung transplant pathology requires improved assessment methods. Novel technologies and standardized data collection are crucial for better lung allograft injury detection and personalized therapies to enhance outcomes.
Area of Science:
- Transplant Pathology
- Allograft Injury Detection
- Lung Transplantation
Background:
- The 2022 16th Banff Foundation Conference's Lung Session addressed non-rejection lung allograft pathology.
- Current methods for assessing lung allograft dysfunction have recognized limitations.
Purpose of the Study:
- To review the current state of lung allograft pathology and novel technologies for detecting allograft injury.
- To discuss the integration of new tools for comprehensive allograft injury assessment and its impact on lung transplant outcomes.
Main Methods:
- A multidisciplinary panel reviewed histopathology, serology, and molecular practices.
- Novel applications of digital pathology, artificial intelligence, gene expression analysis, and quantitative CT imaging were assessed.
Main Results:
- Limitations in current standard of care for assessing lung allograft dysfunction were acknowledged.
- Consensus was reached on the need for standardized pathological data collection, including non-rejection pathology.
- Optimism exists for promising novel, minimally invasive diagnostic modalities.
Conclusions:
- Standardized assessment and data collection are vital for lung allograft pathology.
- Novel diagnostic tools show promise for improving lung transplant outcomes.
- Further multicenter studies are needed to validate new technologies for clinical practice and personalized therapy.
